Fei Miao

Dr. Fei Miao


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YSYu SUN
Yu SUN
QYQihua Yin
Qihua Yin
RFRong Fang
Rong Fang
XYXiaoxiao Yan
Xiaoxiao Yan
YWYing Wang
Ying Wang
JSJunfeng Sun
Junfeng Sun
Although anomalies in the topological architecture of whole-brain connectivity have been found to be associated with Alzheimer’s disease (AD), our understanding about the progression of AD in a functional connectivity (FC) perspective is still rudimentary and few study has explored the function-structure relations in brain networks of AD patients. By using resting-state functional MRI (fMRI), this study firstly investigated organizational alternations in FC networks in 12 AD patients, 15 amnestic mild cognitive impairment (aMCI) patients, and 14 age-matched healthy aging subjects and found that all three groups exhibit economical small-world network properties. Nonetheless, we found a decline of the optimal architecture in the progression of AD, represented by a more localized modular organization with less efficient local information transfer. Our results also show that aMCI forms a boundary between normal aging and AD and represents a functional continuum between healthy aging and the earliest signs of dementia. Moreover, we revealed a dissociated relationship between the overall FC and structural connectivity (SC) in AD patients. In this study, diffusion tensor imaging tractography was used to map the structural network of the same individuals. The decreased FC-SC coupling may be indicative of more stringent and less dynamic brain function in AD patients. Our findings provided insightful implications for understanding the pathophysiological mechanisms of brain dysfunctions in aMCI and AD patients and demonstrated that functional disorders can be characterized by multimodal neuroimaging-based metrics.

1 May 2014 in Inflammatory Bowel Diseases
Verified
Journal Article
Open access
PDF file
XZXue-Song Zhao
Xue-Song Zhao
ZWZheng-Ting Wang
Zheng-Ting Wang
ZWZhi-Yuan Wu
Zhi-Yuan Wu
QYQi-Hua Yin
Qi-Hua Yin
JZJie Zhong
Jie Zhong
FYFu-Hua Yan
Fu-Hua Yan
Background. Crohn's disease (CD) and intestinal tuberculosis (ITB) have similar clinical, radiological, and endoscopic features. The objective of our study was

1 December 2015 in European Journal of Radiology
Verified
Journal Article
Closed access
QYQihua Yin
Qihua Yin
XZXinnong Zou
Xinnong Zou
XZXiaodong Zai
Xiaodong Zai
ZWZhiyuan Wu
Zhiyuan Wu
QWQingyang Wu
Qingyang Wu
FMFei Miao
Fei Miao

27 June 2016 in Small
Verified
Journal Article
Closed access
PDF file
HSHongyuan Shi
Hongyuan Shi
ZWZhiming Wang
Zhiming Wang
CHChusen Huang
Chusen Huang
XGXiaoli Gu
Xiaoli Gu
TJTi Jia
Ti Jia
FMFei Miao
Fei Miao

2 December 2019 in Translational Neurodegeneration
Verified
Journal Article
Open access
PDF file
WTWotu Tian
Wotu Tian
FZFei-Xia Zhan
Fei-Xia Zhan
QLQing Liu
Qing Liu
XLXinghua Luan
Xinghua Luan
CZChao Zhang
Chao Zhang
LCli cao
li cao
Background: CSF1R-related leukoencephalopathy, also known as hereditary diffuse leukoencephalopathy with spheroids (HDLS), is a rare white-matter encephalopathy characterized by motor and neuropsychiatric symptoms due to colony-stimulating factor 1 receptor (CSF1R) gene mutation. Few of CSF1R mutations have been functionally testified and the pathogenesis remains unknown. Methods: In order to investigate clinical and pathological characteristics of patients with CSF1R-related leukoencephalopathy and explore the potential impact of CSF1R mutations, we analyzed clinical manifestations of 15 patients from 10 unrelated families and performed brain biopsy in 2 cases. Next generation sequencing was conducted for 10 probands to confirm the diagnosis. Sanger sequencing, segregation analysis and phenotypic reevaluation were utilized to substantiate findings. Functional examination of identified mutations was further explored. Results: Clinical and neuroimaging characteristics were summarized. The average age at onset was 35.9 ± 6.4 years (range 24–46 years old). Younger age of onset was observed in female than male (34.2 vs. 39.2 years). The most common initial symptoms were speech dysfunction, cognitive decline and parkinsonian symptoms. One patient also had marked peripheral neuropathy. Brain biopsy of two cases showed typical pathological changes, including myelin loss, axonal spheroids, phosphorylated neurofilament and activated macrophages. Electron microscopy disclosed increased mitochondrial vacuolation and disorganized neurofilaments in ballooned axons. A total of 7 pathogenic variants (4 novel, 3 documented) were identified with autophosphorylation deficiency, among which c.2342C > T remained partial function of autophosphorylation. Western blotting disclosed the significantly lower level of c.2026C > T (p.R676*) than wild type. The level of microtubule associated protein 1 light chain 3-II (LC3-II), a classical marker of autophagy, was significantly lower in mutants expressed cells than wild type group by western blotting and immunofluorescence staining. Conclusions: Our findings support the loss-of-function and haploinsufficiency hypothesis in pathogenesis. Autophagy abnormality may play a role in the disease. Repairing or promoting the phosphorylation level of mutant CSF1R may shed light on therapeutic targets in the future. However, whether peripheral polyneuropathy potentially belongs to CSF1R-related spectrum deserves further study with longer follow-up and more patients enrolled. Trial registration: ChiCTR, ChiCTR1800015295. Registered 21 March 2018.

28 January 2013 in La radiologia medica
Verified
Journal Article
Closed access
PDF file
SHShengping Hu
Shengping Hu
SHShudong Hu
Shudong Hu
MWMingliang Wang
Mingliang Wang
ZWZhiyuan Wu
Zhiyuan Wu
FMFei Miao
Fei Miao